Abstract:Functional connectivity (FC) obtained from resting-state functional magnetic resonance imaging has been integrated with machine learning algorithms to deliver consistent and reliable brain disease classification outcomes. However, in classical learning procedures, custom-built specialized feature selection techniques are typically used to filter out uninformative features from FC patterns to generalize efficiently on the datasets. The ability of convolutional neural networks (CNN) and other deep learning models to extract informative features from data with grid structure (such as images) has led to the surge in popularity of these techniques. However, the designs of many existing CNN models still fail to exploit the relationships between entities of graph-structure data (such as networks). Therefore, graph convolution network (GCN) has been suggested as a means for uncovering the intricate structure of brain network data, which has the potential to substantially improve classification accuracy. Furthermore, overfitting in classifiers can be largely attributed to the limited number of available training samples. Recently, the generative adversarial network (GAN) has been widely used in the medical field for its generative aspect that can generate synthesis images to cope with the problems of data scarcity and patient privacy. In our previous work, GCN and GAN have been designed to investigate FC patterns to perform diagnosis tasks, and their effectiveness has been tested on the ABIDE-I dataset. In this paper, the models will be further applied to FC data derived from more public datasets (ADHD, ABIDE-II, and ADNI) and our in-house dataset (PTSD) to justify their generalization on all types of data. The results of a number of experiments show the powerful characteristic of GAN to mimic FC data to achieve high performance in disease prediction. When employing GAN for data augmentation, the diagnostic accuracy across ADHD-200, ABIDE-II, and ADNI datasets surpasses that of other machine learning models, including results achieved with BrainNetCNN. Specifically, in ADHD, the accuracy increased from 67.74% to 73.96% with GAN, in ABIDE-II from 70.36% to 77.40%, and in ADNI, reaching 52.84% and 88.56% for multiclass and binary classification, respectively. GCN also obtains decent results, with the best accuracy in ADHD datasets at 71.38% for multinomial and 75% for binary classification, respectively, and the second-best accuracy in the ABIDE-II dataset (72.28% and 75.16%, respectively). Both GAN and GCN achieved the highest accuracy for the PTSD dataset, reaching 97.76%. However, there are still some limitations that can be improved. Both methods have many opportunities for the prediction and diagnosis of diseases.

Disease prediction using graph convolutional networks: Application to Autism Spectrum Disorder and Alzheimer's disease

Disease prediction with edge-variational graph convolutional networks

Regional Brain Fusion: Graph Convolutional Network for Alzheimer's Disease Prediction and Analysis

A novel interactive deep cascade spectral graph convolutional network with multi-relational graphs for disease prediction

Graph-Based Disease Prediction in Neuroimaging: Investigating the Impact of Feature Selection

AMA-GCN: Adaptive Multi-layer Aggregation Graph Convolutional Network for Disease Prediction

Early prediction of dementia using fMRI data with a graph convolutional network approach

CC- GCN: A novel graph-based approach for identification and detection of autism spectrum disorder

Interpretable Learning Based Dynamic Graph Convolutional Networks for Alzheimer's Disease Analysis.

BCN-GCN: A Novel Brain Connectivity Network Classification Method via Graph Convolution Neural Network for Alzheimer’s Disease

The Use of Generative Adversarial Network and Graph Convolution Network for Neuroimaging-Based Diagnostic Classification

An Overview of Disease Prediction based on Graph Convolutional Neural Network

Dementia classification using a graph neural network on imaging of effective brain connectivity

Adversarially Trained Persistent Homology Based Graph Convolutional Network for Disease Identification Using Brain Connectivity

Graph Convolution Network with Similarity Awareness and Adaptive Calibration for Disease-Induced Deterioration Prediction.

Comorbidity-based framework for Alzheimer's disease classification using graph neural networks

A Graph Convolutional Network Based on Univariate Neurodegeneration Biomarker for Alzheimer's Disease Diagnosis

Population-based GCN method for diagnosis of Alzheimer's disease using brain metabolic or volumetric features

Advancing Alzheimer's Disease Detection Harnessing Graph Convolutional Networks For Enhanced Early Identification

Aiding Alzheimer's Disease Diagnosis Using Graph Convolutional Networks Based on rs-fMRI Data.

FPDGL: Functional-Pathological Dual Graph Learning for Alzheimer’s Disease Diagnosis